Glycemic Control with Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
Phase 4
Not yet recruiting
- Conditions
- Diabetes MellitusType 2 DM
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Nabiqasim Industries (Pvt) Ltd
- Target Recruit Count
- 800
- Registration Number
- NCT06862739
Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy
- First Posted Date
- 2015-03-12
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Nabiqasim Industries (Pvt) Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT02386904
- Locations
- 🇵🇰
National Institute of Liver and GI diseases, DUHS, Karachi, Sindh, Pakistan
© Copyright 2025. All Rights Reserved by MedPath